Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

By Ioannidis Georgios   Souglakos John   Georgoulias Vassilis  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 281-293

Future Medicine

Access to resources Recommend Favorite

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

By                      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

Long-term Prognosis Following Macroscopic Complete Response at Second-look Laparotomy in Advanced Ovarian Cancer Patients Treated with Platinum-based Chemotherapy

By Chiara S.   Lionetto R.   Campora E.   Oliva C.   Merlini L.   Bruzzi P.   Rosso R.   Conte P.F.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 296-301

Elsevier

Access to resources Recommend Favorite

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

By Bonanno L.   Costa C.   Majem M.   Favaretto A.   Rugge M.   Rosell R.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1130-1132

Oxford University Press

Access to resources Recommend Favorite

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy

By Giaccone Giuseppe   Iacona Renee   Fandi Abderrahim   Janas Mette   Ochs Judith   Herbst Roy   Johnson David  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 467-476

Springer Publishing Company

Access to resources Recommend Favorite